CN101020005A - Oral medicine for treating dizziness and its prepn - Google Patents

Oral medicine for treating dizziness and its prepn Download PDF

Info

Publication number
CN101020005A
CN101020005A CN 200710051531 CN200710051531A CN101020005A CN 101020005 A CN101020005 A CN 101020005A CN 200710051531 CN200710051531 CN 200710051531 CN 200710051531 A CN200710051531 A CN 200710051531A CN 101020005 A CN101020005 A CN 101020005A
Authority
CN
China
Prior art keywords
dizzy
parts
medicine
fructus
endo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 200710051531
Other languages
Chinese (zh)
Inventor
秦建华
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 200710051531 priority Critical patent/CN101020005A/en
Publication of CN101020005A publication Critical patent/CN101020005A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to one kind of oral medicine for treating dizziness and its preparation process. The oral medicine is prepared with the Chinese medicinal materials, including gastrodia tuber 10-15 weight portions, red sage 10-15 weight portions, tribulus terrestris 10-15 weight portions, altai anemone rhizome 7-9 weight portions, and pulp of dogwood fruit 7-9 weight portions. It can improve brain blood supply, improve spasm and treating dizziness, and has the advantages of high safety, less side effect, high curative effect, etc.

Description

A kind of oral medicine for the treatment of dizzy giddy and preparation method thereof
Technical field
The present invention relates to a kind of oral medicine for the treatment of dizzy giddy and preparation method thereof.
Background technology
Dizzy, claim again " Menieres disease ", the ataxia that pathogenic factor causes mainly due to interior auricularis edema, the patient feels day to revolve confusedly during morbidity, and nausea and vomiting, photophobia, inactive in the time of seriously are moving then also very; The men and women all can fall ill, and every and tired, morbidity easily repeatedly, does not still have the radical cure way at present when depressed.Dizzy headache, its pathogenic factor is a lot, and the blood supply in brain deficiency is its main cause, and causes that the insufficient reason of blood supply in brain is also a lot; As cerebral arteriosclerosis, cerebral vasospasm, cerebral arteries deformity etc. is its main pathogenic factor.The traditional Chinese medical science is said: " calm do not do dizzy ", " no expectorant is not done to swoon ", and brain is the mansion in Clear and Bright, kidney master marrow leads in brain, and is therefore dizzy, dizzy, have a headache due to all liver-wind is suffered from a deficiency of the kidney, benefiting essence and marrow, it is to treat this sick fundamental law that suppressing the hyperactive liver dispels the wind.
Summary of the invention
The object of the present invention is to provide a kind of oral medicine for the treatment of dizzy giddy and preparation method thereof.
Technical scheme of the present invention is:
A kind ofly treat dizzy, dizzy endo-medicine, it is characterized in that: it is the medicament of being made by the following weight proportion raw material: Rhizoma Gastrodiae 10-15 part, Radix Salviae Miltiorrhizae 10-15 part, Fructus Tribuli 10-15 part, Rhizoma Anemones Altaicae 7-9 part, Fructus Corni 7-9 part.
Treat dizzy, dizzy endo-medicine, it is characterized in that: it is the medicament of being made by the following weight proportion raw material: Rhizoma Gastrodiae 12-15 part, Radix Salviae Miltiorrhizae 12-15 part, Fructus Tribuli 12-15 part, Rhizoma Anemones Altaicae 6-8 part, Fructus Corni 6-8 part.
Treat dizzy, dizzy endo-medicine, it is characterized in that: it is the medicament of being made by the following weight proportion raw material: 15 parts in Rhizoma Gastrodiae, 15 parts of Radix Salviae Miltiorrhizaes, 15 parts of Fructus Tribulis, 8 parts of Rhizoma Anemones Altaicaes, 8 parts of Fructus Corni.
The consumption and the course of treatment: curative effect of the present invention diagnosis does not still have clear and definite standard, and generally be according to the disappearance of symptom or improve as foundation, according to the length of the course of disease, the weight of symptom, or single " dizzy " " giddy " or difference that the two haves both at the same time.In the medication process, each patient's the course of treatment is inequality, varies with each individual, and medication is arranged 1 day, and 3 days, 7 days, 30 days difference was a course of treatment with three days generally.Vertigo general course of treatment; The dizzy headache 3-4 the course of treatment, course of disease person repeatedly can be taken 30 days continuously, and therefore the result who draws from clinical practice the course of treatment of the present invention was advisable for 6-30 days.
Observation index:
1, symptom: giddy, look thing rotation, the companion feels sick, vomiting, tinnitus, nystagmus, limb fiber crops, uncomfortable in chest vexed, dizzy, have a headache.
2, untoward reaction: any untoward reaction that occurs during the treatment is recorded faithfully.
Curative effect is judged:
1 disease evaluation criterion
1.1 it is dizzy, look the thing rotation
1.2 dizzy, headache
1.3 nauseating, vomiting
1.4 tinnitus, nystagmus
1.5 limb fiber crops, weak
1.6 it is uncomfortable in chest vexed
1.7 dizzy, headache
Above symptom is remembered 1 fen respectively, public 6 minutes.
2 curative effect judging standards
2.1 recovery from illness: symptom all disappears, and does not see the recidivist more than 1 year.
2.2 produce effects: dizzy, headgear, look thing rotation and simultaneous phenomenon disappearance or appearance once in a while, treatment back integration descends greater than 2/3.
2.3 effectively: dizzy, look the thing rotation, dizzy, times of headache reduces, simultaneous phenomenon disappears substantially, treatment back integration drops to 2/3,1/3.
2.4 invalid: dizzy, look thing rotation, dizzy, times of headache and simultaneous phenomenon and do not subtract, treatment back integration descends 1/3.
3 clinical effectiveness:
The clinical therapeutic efficacy statistics
Figure A20071005153100041
Illustrate: therapist all is under the invalid situation of various medicines for oral administration, uses the embodiment of the invention 1 used medicine to treat, and is divided into four groups by symptom different random such as dizzy, dizzy, headaches, and its result as above.Matched group is not taken this medicine, and the Thebe of adopting medicine Xi'an Janssen Pharmaceutica factory to produce is peaceful, every day 2 times, and each 5mg, 5 days is one-period.
According to the result of clinical treatment as can be seen, curative effect of the present invention is still very definite, and as for invalid, mainly based on Algopsychalia, and the course of disease itself is very long, and the treatment difficulty is bigger.
Medical record is given an example:
Example 1: San Wei village, the Jiang Xiang of Nanchang County town women student one people.25 years old, the city defended the school graduation in 2000, and just often sexy dizzy, dizzy when defending the proofreading book, as carsickness, annual outbreak 2-3 time does not need medication, as long as just the spontaneous remission in 1-2 days of taking a quick nap during outbreak.The private hospital manual labour in Zhuhai in 2004, consider because of work labor during this time, outbreak is frequent, and the sense sky is dizzy confusedly during recurrence, companion's nausea and vomiting, photophobia, inactive, moving then also very, must the drop glucose, aminoacid etc. still can alleviate in one week of medicine, arrived provinces and cities' hospitalize once, be diagnosed as " Meniere's disease ".Outbreak in patient 2-30 days once, symptom can't be improved, and, takes " dizzy pain is relaxed " 3 days transference cures in mid-April, 2005 here treatment, take 9 days one as usual, Zhuhai recurrence of doing manual work so far now.
Example 2: son peace road one people of Nanchang City, women, 49 years old, professional accounting.The giddy 2-3 when the time comes that suffers from headaches used medicines such as the Thebe is peaceful, breviscapine, Fructus Liquidambaris, rheoencephalogram prompting " cerebral vasospasm ", accept " dizzy pain is relaxed " treatment on May 16th, 2006, take 3 days doing well,improvings, symptom disappears entirely after 6 days, check rheoencephalogram behind the first quarter moon, all are normal.
Example 3: Nanchang City's retirement veteran cadre one people, the male, 80 years old, suffer from dizzy headache and last 20 years, is cerebral arteriosclerosis at provincial hospital through EEG (electrocardiogram) examination, uses successively that the Thebe is peaceful, breviscapine etc. is invalid, takes on November 20th, 2006 " dizzy pain is relaxed ", symptom disappears entirely after three days, and drug withdrawal is not recurrence so far.
Example 4: No. 519 one people in ship hill path, Nanchang City, the women 53 years old, suffers from dizzy lasting more than 10 years, do brain magnetic resonance inspection prompting cerebral arteries deformity economizing an attached institute, successively used medicines such as the Thebe is peaceful, breviscapine, ZHENNAONING, Folium Ginkgo invalid, and accepted " dizzy pain is relaxed " treatment on November 8th, 2006, taking 2 days symptoms promptly improves, intermittently take now always, the patient does not feel like oneself voluntarily after drug withdrawal 2-3 days, therefore just takes whenever doing not feel like oneself, and adheres to so far.
The invention has the advantages that: security performance for oral administration is strong, and curative effect is great advantage of the present invention soon, and relatively littler to the toxic and side effects probability that human body brings with other oral medicine, this also is the common sensation of patient.The patient does not take untoward reaction such as the regurgitation, flatulence of this medicine, and from clinical, curative effect is fast, and remission is difficult for repeatedly, and short treating period is cheap.The limited brain blood supply that improves of the present invention's energy improves spasm, treats dizzy giddy.
The specific embodiment
Embodiment 1, dizzy, the dizzy endo-medicine of treatment, wherein: it is the medicament of being made by the following weight proportion raw material: Rhizoma Gastrodiae 10-15 part, Radix Salviae Miltiorrhizae 10-15 part, Fructus Tribuli 10-15 part, Rhizoma Anemones Altaicae 7-9 part, Fructus Corni 7-9 part.
Embodiment 2, dizzy, the dizzy endo-medicine of treatment, wherein: it is the medicament of being made by the following weight proportion raw material: Rhizoma Gastrodiae 12-15 part, Radix Salviae Miltiorrhizae 12-15 part, Fructus Tribuli 12-15 part, Rhizoma Anemones Altaicae 6-8 part, Fructus Corni 6-8 part.
Embodiment 3, dizzy, the dizzy endo-medicine of treatment, wherein: it is the medicament of being made by the following weight proportion raw material: 15 parts in Rhizoma Gastrodiae, 15 parts of Radix Salviae Miltiorrhizaes, 15 parts of Fructus Tribulis, 8 parts of Rhizoma Anemones Altaicaes, 8 parts of Fructus Corni.
The preparation method of embodiment 4, dizzy, the dizzy endo-medicine of treatment, wherein: get Rhizoma Gastrodiae by weight ratio, Radix Salviae Miltiorrhizae, Fructus Tribuli, Rhizoma Anemones Altaicae, the crude drug that Fructus Corni is formed amounts to 1000g, prepares by following method: the pretreatment of A crude drug: with Rhizoma Gastrodiae, and Radix Salviae Miltiorrhizae, Fructus Tribuli, Rhizoma Anemones Altaicae, Fructus Corni cleans up respectively, the Rhizoma Gastrodiae shave; B decocts: add 7000 ml waters for the first time and decocted 2 hours, filter time medicinal liquid of winning; Add for the second time 3000 ml waters decoct filtered in 1 hour medicinal liquid for the second time, the secondary medicinal liquid merges to concentrate and concentrates; Can be packed as oral liquid when being concentrated into 625 milliliters.All the other are with embodiment 3.
The preparation method of embodiment 5, dizzy, the dizzy endo-medicine of treatment, wherein: oral liquid is continued to concentrate, to proportion be 1.12 o'clock, get 1 part of condensed cream, add 0.2 part of microcrystalline Cellulose, 0.5 part of low-substituted hydroxypropyl cellulose, 0.1 part of crospolyvinylpyrrolidone, add 3 parts of dissolvings of water, make soft material; 20 mesh sieves are made wet granular, drying, and 20 mesh sieve granulate, tabletting become tablet or the granule behind the granulate are filled in the capsule.All the other are with embodiment 4.
Embodiment 6, dizzy, the dizzy endo-medicine of treatment, wherein: it is the medicament of being made by the following weight proportion raw material: 10 parts in Rhizoma Gastrodiae, 15 parts of Radix Salviae Miltiorrhizaes, 10 parts of Fructus Tribulis, 9 parts of Rhizoma Anemones Altaicaes, 7 parts of Fructus Corni.All the other are with embodiment 3.
Embodiment 7, dizzy, the dizzy endo-medicine of treatment, wherein: it is the medicament of being made by the following weight proportion raw material: 15 parts in Rhizoma Gastrodiae, 10 parts of Radix Salviae Miltiorrhizaes, 15 parts of Fructus Tribulis, 7 parts of Rhizoma Anemones Altaicaes, 9 parts of Fructus Corni.All the other are with embodiment 3.
Embodiment 8, dizzy, the dizzy endo-medicine of treatment, wherein: it is the medicament of being made by the following weight proportion raw material: 12 parts in Rhizoma Gastrodiae, 15 parts of Radix Salviae Miltiorrhizaes, 12 parts of Fructus Tribulis, 6 parts of Rhizoma Anemones Altaicaes, 8 parts of Fructus Corni.All the other are with embodiment 4.
Embodiment 9, dizzy, the dizzy endo-medicine of treatment, wherein: it is the medicament of being made by the following weight proportion raw material: 15 parts in Rhizoma Gastrodiae, 12 parts of Radix Salviae Miltiorrhizaes, 15 parts of Fructus Tribulis, 8 parts of Rhizoma Anemones Altaicaes, 6 parts of Fructus Corni.All the other are with embodiment 4.
Embodiment 9, dizzy, the dizzy endo-medicine of treatment, wherein: it is the medicament of being made by the following weight proportion raw material: 13 parts in Rhizoma Gastrodiae, 13 parts of Radix Salviae Miltiorrhizaes, 14 parts of Fructus Tribulis, 7 parts of Rhizoma Anemones Altaicaes, 7 parts of Fructus Corni.All the other are with embodiment 4.

Claims (5)

1, a kind ofly treat dizzy, dizzy endo-medicine, it is characterized in that: it is the medicament of being made by the following weight proportion raw material: Rhizoma Gastrodiae 10-15 part, Radix Salviae Miltiorrhizae 10-15 part, Fructus Tribuli 10-15 part, Rhizoma Anemones Altaicae 7-9 part, Fructus Corni 7-9 part.
2, dizzy, the dizzy endo-medicine of treatment according to claim 1, it is characterized in that: it is the medicament of being made by the following weight proportion raw material: Rhizoma Gastrodiae 12-15 part, Radix Salviae Miltiorrhizae 12-15 part, Fructus Tribuli 12-15 part, Rhizoma Anemones Altaicae 6-8 part, Fructus Corni 6-8 part.
3, dizzy, the dizzy endo-medicine of treatment according to claim 1 is characterized in that: it is the medicament of being made by the following weight proportion raw material: 15 parts in Rhizoma Gastrodiae, 15 parts of Radix Salviae Miltiorrhizaes, 15 parts of Fructus Tribulis, 8 parts of Rhizoma Anemones Altaicaes, 8 parts of Fructus Corni.
4, the preparation method of dizzy, the dizzy endo-medicine of the described treatment of claim 3, it is characterized in that: get Rhizoma Gastrodiae by weight ratio, Radix Salviae Miltiorrhizae, Fructus Tribuli, Rhizoma Anemones Altaicae, the crude drug that Fructus Corni is formed amounts to 1000g, prepares by following method: the pretreatment of A crude drug: with Rhizoma Gastrodiae, and Radix Salviae Miltiorrhizae, Fructus Tribuli, Rhizoma Anemones Altaicae, Fructus Corni cleans up respectively, the Rhizoma Gastrodiae shave; B decocts: add 7000 ml waters for the first time and decocted 2 hours, filter time medicinal liquid of winning; Add for the second time 3000 ml waters decoct filtered in 1 hour medicinal liquid for the second time, the secondary medicinal liquid merges to concentrate and concentrates; Can be packed as oral liquid when being concentrated into 625 milliliters.
5, the preparation method of dizzy, the dizzy endo-medicine of treatment according to claim 4, it is characterized in that: oral liquid is continued to concentrate, to proportion be 1.12 o'clock, get 1 part of condensed cream, add 0.2 part of microcrystalline Cellulose, 0.5 part of low-substituted hydroxypropyl cellulose, 0.1 part of crospolyvinylpyrrolidone, add 3 parts of dissolvings of water, make soft material; 20 mesh sieves are made wet granular, drying, and 20 mesh sieve granulate, tabletting become tablet or the granule behind the granulate are filled in the capsule.
CN 200710051531 2007-02-09 2007-02-09 Oral medicine for treating dizziness and its prepn Pending CN101020005A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 200710051531 CN101020005A (en) 2007-02-09 2007-02-09 Oral medicine for treating dizziness and its prepn

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 200710051531 CN101020005A (en) 2007-02-09 2007-02-09 Oral medicine for treating dizziness and its prepn

Publications (1)

Publication Number Publication Date
CN101020005A true CN101020005A (en) 2007-08-22

Family

ID=38707931

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 200710051531 Pending CN101020005A (en) 2007-02-09 2007-02-09 Oral medicine for treating dizziness and its prepn

Country Status (1)

Country Link
CN (1) CN101020005A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101254291B (en) * 2008-03-26 2010-09-01 都芳鹃 Medicament for curing cervical vertigo
CN102648964A (en) * 2011-02-28 2012-08-29 王春玉 Medicine for treating headache, hypertension and cardiovascular and cerebrovascular disease

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101254291B (en) * 2008-03-26 2010-09-01 都芳鹃 Medicament for curing cervical vertigo
CN102648964A (en) * 2011-02-28 2012-08-29 王春玉 Medicine for treating headache, hypertension and cardiovascular and cerebrovascular disease

Similar Documents

Publication Publication Date Title
CN100457176C (en) Chinese medicinal preparation for curriculum of physical and fatigue reducing
CN102526474B (en) Chinese medicine composition for treating neurasthenia
CN1985965A (en) Medicine for treating coronary heart disease and cerebral thrombus and its preparing method
CN102178800A (en) Chinese medicine composition for treating rheumatoid arthritis and preparation method thereof
CN102166278B (en) Chinese medicinal composition for treating pediatric rheumatoid arthritis and preparation method thereof
CN102988905B (en) Traditional Chinese medicine preparation for treating epilepsia and preparation method thereof
CN102631647A (en) Chinese patent medicine mixture for treating acute urticaria
CN103301267A (en) Traditional Chinese medicine composition for treating hypertension and/or atherosclerosis and application thereof
CN104288624A (en) Pharmaceutical composition and application thereof
CN101700336B (en) Chinese herba preparation for curing craniocerebra trauma residual headache and preparation method
CN102973674A (en) Eczema eliminating capsule
CN102847061B (en) Traditional Chinese medicine preparation for treating pediatric viral myocarditis and preparation method thereof
CN100394933C (en) Application of 'Guizhi Gancao Longgu Muli' preparation in preparation of medicine for preventing and treating depression
CN103239562B (en) Traditional Kazak medicament composition for treating diabetes mellitus and preparation method of traditional Kazak medicament composition
CN101020005A (en) Oral medicine for treating dizziness and its prepn
CN101548993B (en) Application of Japanese climbing fern spore in preparing lead excretion medicines or health products
CN104758578A (en) Traditional Chinese medicine composition for treating palpitation
CN104605051A (en) Double hemp-folium cortex eucommiae tea and preparing method thereof
CN102631648A (en) Chinese patent medicine for treating acute urticaria
CN104288636B (en) Medical composition and its use
CN100512865C (en) External application medicine for treating hypertension
CN102895352B (en) Pharmaceutical composition and application thereof
CN102641424A (en) Chinese patent medicine mixture for treating acute urticaria
CN102631483A (en) Traditional Chinese medicine (TCM) for treating acute urticaria
CN102641381A (en) Chinese patent medicine for treating acute urticaria

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
AD01 Patent right deemed abandoned

Effective date of abandoning: 20070822

C20 Patent right or utility model deemed to be abandoned or is abandoned